logo

For the Inventor, By the Inventor

Hamilton, Bermuda

Forest Laboratories Holdings Limited


USPTO Granted Patents = 26

% Expired Patents = 42.3



Trademarks = 2

Forward Citations = 112

Loading Chart...
Loading Chart...

73 inventors (with patents filed for the assignee):

goldMedal Mahendra G Dedhiya (9 out of 24 patents)

silverMedal Yun Mo (4 out of 5 patents)

bronzeMedal Melanie Simone Ronsheim (4 out of 7 patents)

4.  Gian-Luca Araldi (4 out of 6 patents)

5.  Angelika Fretzen (3 out of 21 patents)

6.  Niranjan Rao (3 out of 3 patents)

7.  Antonia Periclou (3 out of 3 patents)

8.  Wattanaporn Abramowitz (3 out of 3 patents)

9.  Shao Hong Zhou (3 out of 7 patents)

10.  Yuriy B Kalyan (3 out of 7 patents)

11.  Matthew Ronsheim (3 out of 7 patents)

12.  Nhut Diep (3 out of 6 patents)

13.  Alexander Bischoff (3 out of 6 patents)

14.  Sunil Sadanand Nadkarni (2 out of 14 patents)

15.  Alistair John Boyd (2 out of 5 patents)


Core Competencies:
Linaclotide
Memantine
Heterocyclic Compounds
Nebivolol
A2AR Agonists
Xanthine Compounds
GC-C Receptor Agonist
Crystalline Forms
Piperazine Derivatives
Pyrazolyl Substitutes
Pharmaceutical Compositions
CNS Disorders

26 patents:

1. 10702576 - Stable formulations of linaclotide (2020-07-07),
2. 10675325 - Stable formulations of linaclotide (2020-06-09),
3. 10660868 - Modified release formulations of memantine oral dosage forms (2020-05-26),
4. 9695122 - Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof (2017-07-04),
5. 9580424 - Crystalline forms of trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide sodium salt (2017-02-28),
6. 9284314 - Processes for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide and salts thereof (2016-03-15),
7. 9283261 - Linaclotide compositions (2016-03-15),
8. 9221821 - Methods for the synthesis of 1,3-substituted aminouracils and other xanthine-related compounds (2015-12-29),
9. 8834924 - Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane (2014-09-16),
10. 8802628 - Stable solid formulation of a GC-C receptor agonist polypeptide suitable for oral administration (2014-08-12),
11. 8633241 - Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol (2014-01-21),
12. 8604222 - Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol (2013-12-10),
13. 8222228 - Substituted aryl piperidinylalkynyladenosines as A2AR agonists (2012-07-17),
14. 8153628 - Pyrazolyl substituted xanthines (2012-04-10),
15. 8044041 - Phthalazine derivatives as inhibitors of protein kinase (2011-10-25),
Company Overview
Forest Laboratories Holdings Limited is a biopharmaceutical company based in Hamilton, Bermuda, specializing in the development and commercialization of innovative therapies. The organization focuses on addressing unmet medical needs across various therapeutic areas, including psychiatry, neurology, and cardiovascular health. With a commitment to research and development, Forest Laboratories aims to enhance patient outcomes through advanced drug formulations and targeted treatment strategies, contributing to the global healthcare landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

26 Patents

#27 in Hamilton

#30 in Bermuda

#24,826 in the World

Hamilton, BM
Hamilton, Bermuda

Forest Laboratories Holdings Limited

Forward Citations = 112

73 inventors:

goldMedal Mahendra G Dedhiya (9 out of 24 patents)

silverMedal Yun Mo (4 out of 5 patents)

bronzeMedal Melanie Simone Ronsheim (4 out of 7 patents)

4.  Gian-Luca Araldi (4 out of 6 patents)

5.  Angelika Fretzen (3 out of 21 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Forest Laboratories Holdings Limited. Retrieved from https://idiyas.com/company/forest-laboratories-holdings

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…